• Guideline Summary
  • NGC:009802
  • 2012 Jun (revised 2013 Mar)

Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

  • Guideline Summary
  • NGC:010400
  • 1998 Jun (revised 2014 May)

Venous thromboembolism (VTE).

  • Guideline Summary
  • NGC:009105
  • 2000 Jun (revised 2012 Apr)

Guidelines on the investigation and management of antiphospholipid syndrome.

  • Guideline Summary
  • NGC:009949
  • 2013 Jun

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism.

  • Guideline Summary
  • NGC:010791
  • 2015 Aug

Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism.

  • Guideline Summary
  • NGC:010622
  • 2014 Dec

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.

  • Guideline Summary
  • NGC:009304
  • 1999 Mar (revised Aug 2012; republished 2013 Jun)

Antithrombotics: indications and management. A national clinical guideline.

  • Guideline Summary
  • NGC:010743
  • 2007 Apr (revised 2015 Jun)

Venous thromboembolism in adults admitted to hospital: reducing the risk.

  • Guideline Summary
  • NGC:010432
  • 1998 Nov 1 (revised 2014 June 10)

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  • Guideline Summary
  • NGC:010951
  • 2016 Feb

Antithrombotic therapy for VTE disease: CHEST guideline and Expert Panel report.